Yasuno H - Search Results

1

Antitumor activity of chemoendocrine therapy in premenopausal and postmenopausal models with human breast cancer xenografts.

Kataoka M, Yamaguchi Y, Moriya Y, Sawada N, Yasuno H, Kondoh K, Evans DB, Mori K, Hayashi S. Kataoka M, et al. Among authors: yasuno h. Oncol Rep. 2012 Feb;27(2):303-10. doi: 10.3892/or.2011.1541. Epub 2011 Nov 9. Oncol Rep. 2012. PMID: 22076074

2

Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models.

Fujimoto-Ouchi K, Sekiguchi F, Yasuno H, Moriya Y, Mori K, Tanaka Y. Fujimoto-Ouchi K, et al. Among authors: yasuno h. Cancer Chemother Pharmacol. 2007 May;59(6):795-805. doi: 10.1007/s00280-006-0337-z. Epub 2006 Oct 10. Cancer Chemother Pharmacol. 2007. PMID: 17031648

3

Novel models of cancer-related anemia in mice inoculated with IL-6-producing tumor cells.

Mori K, Fujimoto-Ouchi K, Onuma E, Noguchi M, Shimonaka Y, Yasuno H, Nishimura T. Mori K, et al. Among authors: yasuno h. Biomed Res. 2009 Feb;30(1):47-51. doi: 10.2220/biomedres.30.47. Biomed Res. 2009. PMID: 19265263 Free article.

4

Biomarkers for antitumor activity of bevacizumab in gastric cancer models.

Yamashita-Kashima Y, Fujimoto-Ouchi K, Yorozu K, Kurasawa M, Yanagisawa M, Yasuno H, Mori K. Yamashita-Kashima Y, et al. Among authors: yasuno h. BMC Cancer. 2012 Jan 25;12:37. doi: 10.1186/1471-2407-12-37. BMC Cancer. 2012. PMID: 22273502 Free PMC article.

5

Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes.

Yasuno H, Kurasawa M, Yanagisawa M, Sato Y, Harada N, Mori K. Yasuno H, et al. Oncol Rep. 2013 Feb;29(2):451-8. doi: 10.3892/or.2012.2149. Epub 2012 Nov 27. Oncol Rep. 2013. PMID: 23229803

6

Melting curve analysis for mutations of EGFR and KRAS.

Furugaki K, Yasuno H, Iwai T, Moriya Y, Harada N, Fujimoto-Ouchi K. Furugaki K, et al. Among authors: yasuno h. Anticancer Res. 2014 Feb;34(2):613-21. Anticancer Res. 2014. PMID: 24510990

7

Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice.

Sasaki Y, Noguchi-Sasaki M, Yasuno H, Yorozu K, Shimonaka Y. Sasaki Y, et al. Among authors: yasuno h. Int J Hematol. 2012 Dec;96(6):692-700. doi: 10.1007/s12185-012-1217-4. Epub 2012 Nov 16. Int J Hematol. 2012. PMID: 23160767

8

Reduction of a marker of oxidative stress with enhancement of iron utilization by erythropoiesis activation following epoetin beta pegol administration in iron-loaded db/db mice.

Noguchi-Sasaki M, Sasaki Y, Matsuo-Tezuka Y, Yasuno H, Kurasawa M, Yorozu K, Shimonaka Y. Noguchi-Sasaki M, et al. Among authors: yasuno h. Int J Hematol. 2016 Mar;103(3):262-73. doi: 10.1007/s12185-015-1929-3. Epub 2016 Jan 6. Int J Hematol. 2016. PMID: 26739261

9

1α,25(OH)2D3 downregulates gene expression levels of muscle ubiquitin ligases MAFbx and MuRF1 in human myotubes.

Hayakawa N, Fukumura J, Yasuno H, Fujimoto-Ouchi K, Kitamura H. Hayakawa N, et al. Among authors: yasuno h. Biomed Res. 2015;36(2):71-80. doi: 10.2220/biomedres.36.71. Biomed Res. 2015. PMID: 25876656 Free article.

10

Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up.

Murao N, Ishigai M, Yasuno H, Shimonaka Y, Aso Y. Murao N, et al. Among authors: yasuno h. Rapid Commun Mass Spectrom. 2007;21(24):4033-8. doi: 10.1002/rcm.3319. Rapid Commun Mass Spectrom. 2007. PMID: 18000836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters